Skip to NavigationSkip to content

Pharmafile - Research and Development News

Novartis has been rocked by new Phase 3 data from a global trial into the efficacy of Entresto, revealing that the therapy failed to meet its...
FDA approves nine generic versions of Pfizer's Lyrica, NICE to review decision-making process, and Biohaven's amyotrophic lateral sclerosis drug...
Research from University College London has warned that freshwater sources in the English capital of London contain high levels of antibiotic-...
New Phase 3 data has been released on Johnson & Johnson’s selective sphingosine-1-phosphate receptor 1 (S1P1) modulator ponesimod, reporting...
Bristol-Myers Squibb has pulled back the veil on new data from two analyses of its blockbuster immunotherapy Opdivo (nivolumab) in the first-line...
MRI scans can predict MS patient’s long term prognosis when they are first diagnosed, according to new research.
Researchers at Purdue University are developing a device that would automatically detect an overdose in opioid users and release a burst of...
The approval for the drug, known as Hadlima, covers the treatment of rheumatoid arthritis (RA), juvenile idiopathic arthritis, psoriatic arthritis,...
The Senate Finance Committee has introduced a bipartisan bill that aimed at lowering the prices Medicare pays for pharmaceutical drugs.
Pfizer has seen Ruxience, its biosimilar version of Genentech’s Rituxan, approved by the FDA in the treatment of non-Hodgkin lymphoma, chronic...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches